Structure via PubChem · Public domain (PubChem)
pranlukast
Sign in to saveAlso known as ONO RS-411, ONO-RS 411
Pranlukast (brand name Onon, オノン) is a cysteinyl leukotriene receptor-1 antagonist. This drug works similarly to Merck & Co.'s montelukast (Singulair). It is widely used in Japan.
Key facts
- Drug.PubChem
- 4887
- Drug.Watchedfields
- changed
- Drug.verifiedrevid
- 464213227
- Drug.IUPAC_name
- N-[4-oxo-2-(1H-tetrazol-5-yl)-4H-chromen-8-yl]-4-(4-phenylbutoxy)benzamide
- Drug.image
- Pranlukast.svg
- Drug.image_class
- skin-invert-image
- Drug.tradename
- Onon (オノン)
- Drug.routes_of_administration
- Oral
- Drug.metabolism
- Hepatic (mainly CYP3A4)
- Drug.elimination_half life
- 1.5 hours
- Drug.IUPHAR_ligand
- 3634
- Drug.CAS_number
- 103177-37-3
- Drug.ATC_prefix
- R03
- Drug.ATC_suffix
- DC02
- Drug.DrugBank
- DB01411
- Drug.ChemSpiderID
- 4718
- Drug.UNII
- TB8Z891092
- Drug.ChEMBL
- 21333
via Wikipedia infobox
Chemical data
- Formula
- C27H23N5O4
- Molecular weight
- 481.5 g/mol
- IUPAC name
- N-[4-oxo-2-(2H-tetrazol-5-yl)chromen-8-yl]-4-(4-phenylbutoxy)benzamide
- SMILES
- C1=CC=C(C=C1)CCCCOC2=CC=C(C=C2)C(=O)NC3=CC=CC4=C3OC(=CC4=O)C5=NNN=N5
- InChIKey
- NBQKINXMPLXUET-UHFFFAOYSA-N
- XLogP
- 4.2
- Polar surface area
- 119 Ų
- H-bond donors
- 2
- H-bond acceptors
- 7
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Max clinical phase
- Approved
- Molecule type
- Small molecule
- First approval
- 1995
- Admin. routes
- oral
- Indications
- sinusitis, Airway obstruction, seasonal allergic rhinitis
via ChEMBL · EBI
Research
499 papers- Pranlukast: a review of its use in the management of asthma.Drugs · 2003
- Leukotriene receptor antagonists pranlukast and montelukast for treating asthma.Expert opinion on pharmacotherapy · 2014
- Metabolite Dysregulation by Pranlukast in Mycobacterium tuberculosis.Molecules (Basel, Switzerland) · 2022
- Pranlukast Antagonizes CD49f and Reduces Stemness in Triple-Negative Breast Cancer Cells.Drug design, development and therapy · 2020
- Pranlukast treatment and the use of respiratory support in infants with respiratory syncytial virus infection.PloS one · 2022
via PubMed
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 481.175004
- Has use
- medication
Show 2 more facts
- chemical formula
- C₂₇H₂₃N₅O₄
- canonical SMILES
- C1=CC=C(C=C1)CCCCOC2=CC=C(C=C2)C(=O)NC3=CC=CC4=C3OC(=CC4=O)C5=NNN=N5
Sources (2)
via Wikidata · CC0
~1 min read
Encyclopedic overview
1 sectionsContents
- References
Pranlukast (brand name Onon, オノン) is a cysteinyl leukotriene receptor-1 antagonist. This drug works similarly to Merck & Co.'s montelukast (Singulair). It is widely used in Japan.
Medications of this class, which go under a variety of names according to whether one looks at the American, British or European system of nomenclature, have as their primary function the antagonism of bronchospasm caused, principally in asthmatics, by an allergic reaction to accidentally or inadvertently encountered allergens.
Excerpted from Wikipedia’s “pranlukast” article, available under the CC BY-SA 4.0 licence.
Available in 10 languages
via Wikidata sitelinks · CC0